Difference between revisions of "PEDS5:Volunteer Assignments and Opportunities"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
VisualWikitext
[checked revision][checked revision]
 
(12 intermediate revisions by the same user not shown)
Line 6: Line 6:
  
 
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
 
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
 +
 +
__TOC__
 
{| class="wikitable" style="margin:auto"
 
{| class="wikitable" style="margin:auto"
 
|+<big>WHO Classification of Paediatric Tumours (5th Edition) Content</big>
 
|+<big>WHO Classification of Paediatric Tumours (5th Edition) Content</big>
Line 17: Line 19:
 
!'''Notes'''
 
!'''Notes'''
 
|-
 
|-
 +
|
 +
==== CHAPTER 2 (HAEMATOLYMPHOID DISORDERS) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[PEDS5:Chronic_myeloid_leukaemia_(CML)|Chronic myeloid leukaemia (CML)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Juvenile_myelomonocytic_leukaemia|Juvenile myelomonocytic leukaemia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Refractory_cytopenia_of_childhood|Refractory cytopenia of childhood]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Myelodysplastic_syndrome_with_excess_blasts|Myelodysplastic syndrome with excess blasts]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Acute_myeloid_leukaemias_(AMLs)_defined_by_differentiation|Acute myeloid leukaemias (AMLs) defined by differentiation]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Acute_myeloid_leukaemias_(AMLs)_with_defining_genetic_abnormalities|Acute myeloid leukaemias (AMLs) with defining genetic abnormalities]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Myeloid_neoplasms_associated_with_germline_predisposition_|Myeloid neoplasms associated with germline predisposition]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Myeloid_proliferations_associated_with_Down_syndrome|Myeloid proliferations associated with Down syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Mastocytosis|Mastocytosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:B-lymphoblastic_leukaemia/lymphoma|B-lymphoblastic leukaemia/lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:T-_and_NK-lymphoblastic_leukaemia/lymphoma|T- and NK-lymphoblastic leukaemia/lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Primary_mediastinal_large_B-cell_lymphoma|Primary mediastinal large B-cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Diffuse_large_B-cell_lymphoma_NOS|Diffuse large B-cell lymphoma NOS]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:EBV-positive_diffuse_large_B-cell_lymphoma|EBV-positive diffuse large B-cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Large_B-cell_lymphoma_with_IRF4_rearrangement|Large B-cell lymphoma with IRF4 rearrangement]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Paediatric-type_follicular_lymphoma|Paediatric-type follicular lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Paediatric_nodal_marginal_zone_lymphoma|Paediatric nodal marginal zone lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:ALK-positive_large_B-cell_lymphoma|ALK-positive large B-cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Lymphomatoid_granulomatosis|Lymphomatoid granulomatosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Plasmablastic_lymphoma|Plasmablastic lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Mediastinal_grey_zone_lymphoma|Mediastinal grey zone lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Burkitt_lymphoma|Burkitt lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Large_B-cell_lymphoma_with_11q_aberration|Large B-cell lymphoma with 11q aberration]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Peripheral_T-cell_lymphoma_NOS|Peripheral T-cell lymphoma NOS]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Aggressive_NK-cell_leukaemia|Aggressive NK-cell leukaemia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Mycosis_fungoides|Mycosis fungoides]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Primary_cutaneous_CD30-positive_T-cell_lymphoproliferative_disorders|Primary cutaneous CD30-positive T-cell lymphoproliferative disorders]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Subcutaneous_panniculitis-like_T-cell_lymphoma|Subcutaneous panniculitis-like T-cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:ALK-positive_anaplastic_large_cell_lymphoma|ALK-positive anaplastic large cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Hepatosplenic_T-cell_lymphoma|Hepatosplenic T-cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Systemic_EBV-positive_T-cell_lymphoma_of_childhood|Systemic EBV-positive T-cell lymphoma of childhood]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Hydroa_vacciniforme_lymphoproliferative_disorder_|Hydroa vacciniforme lymphoproliferative disorder]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 27: Line 392:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Classic_Hodgkin_lymphoma|Classic Hodgkin lymphoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 36: Line 403:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Nodular_lymphocyte-predominant_Hodgkin_lymphoma|Nodular lymphocyte-predominant Hodgkin lymphoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 45: Line 414:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Langerhans_cell_histiocytosis_and_related_disorders|Langerhans cell histiocytosis and related disorders]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 54: Line 425:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Primary_immunodeficiency-associated_lymphoproliferative_disorders|Primary immunodeficiency-associated lymphoproliferative disorders]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 63: Line 436:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Posttransplant_lymphoproliferative_disorders|Posttransplant lymphoproliferative disorders]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 72: Line 447:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:HIV-associated_lymphoproliferative_disorders|HIV-associated lymphoproliferative disorders]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 81: Line 458:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
 
 
|
 
|
 +
==== CHAPTER 3 (CNS TUMOURS) ====
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Diffuse_astrocytoma,_MYB-_or_MYBL1-altered|Diffuse astrocytoma, MYB- or MYBL1-altered]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 99: Line 490:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Angiocentric_glioma|Angiocentric glioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 108: Line 501:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Polymorphous_low-grade_neuroepithelial_tumour_of_the_young|Polymorphous low-grade neuroepithelial tumour of the young]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 117: Line 512:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Diffuse_low-grade_glioma,_MAPK_pathway-altered|Diffuse low-grade glioma, MAPK pathway-altered]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 126: Line 523:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Diffuse_midline_glioma,_H3_K27-altered|Diffuse midline glioma, H3 K27-altered]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 135: Line 534:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Diffuse_hemispheric_glioma,_H3_G34-mutant|Diffuse hemispheric glioma, H3 G34-mutant]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 144: Line 545:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Diffuse_paediatric-type_high-grade_glioma,_H3-wildtype_and_IDH-wildtype|Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 153: Line 556:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Infant-type_hemispheric_glioma|Infant-type hemispheric glioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 162: Line 567:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Pilocytic_astrocytoma|Pilocytic astrocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 171: Line 578:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:High-grade_astrocytoma_with_piloid_features|High-grade astrocytoma with piloid features]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 180: Line 589:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Pleomorphic_xanthoastrocytoma|Pleomorphic xanthoastrocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 189: Line 600:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Subependymal_giant_cell_astrocytoma|Subependymal giant cell astrocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 198: Line 611:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Astroblastoma,_MN1-altered|Astroblastoma, MN1-altered]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 207: Line 622:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Ganglioglioma|Ganglioglioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 216: Line 633:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Desmoplastic_infantile_ganglioglioma_/_desmoplastic_infantile_astrocytoma|Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 225: Line 644:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Dysembryoplastic_neuroepithelial_tumour|Dysembryoplastic neuroepithelial tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 234: Line 655:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Diffuse_glioneuronal_tumour_with_oligodendroglioma-like_features_and_nuclear_clusters|Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 243: Line 666:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Diffuse_leptomeningeal_glioneuronal_tumour|Diffuse leptomeningeal glioneuronal tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 252: Line 677:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Multinodular_and_vacuolating_neuronal_tumour|Multinodular and vacuolating neuronal tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 261: Line 688:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Supratentorial_ependymoma|Supratentorial ependymoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 270: Line 699:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Supratentorial_ependymoma,_ZFTA_fusion-positive|Supratentorial ependymoma, ZFTA fusion-positive]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 279: Line 710:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Supratentorial_ependymoma,_YAP1_fusion-positive|Supratentorial ependymoma, YAP1 fusion-positive]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 288: Line 721:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Posterior_fossa_ependymoma|Posterior fossa ependymoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 297: Line 732:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Posterior_fossa_group_A_(PFA)_ependymoma|Posterior fossa group A (PFA) ependymoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 306: Line 743:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Posterior_fossa_group_B_(PFB)_ependymoma|Posterior fossa group B (PFB) ependymoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 315: Line 754:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Spinal_ependymoma,_MYCN-amplified|Spinal ependymoma, MYCN-amplified]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 324: Line 765:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Myxopapillary_ependymoma|Myxopapillary ependymoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 333: Line 776:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Choroid_plexus_papilloma|Choroid plexus papilloma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 342: Line 787:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Atypical_choroid_plexus_papilloma|Atypical choroid plexus papilloma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 351: Line 798:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Choroid_plexus_carcinoma|Choroid plexus carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 360: Line 809:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Medulloblastoma,_WNT-activated|Medulloblastoma, WNT-activated]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 369: Line 820:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Medulloblastoma,_SHH-activated_and_TP53-wildtype|Medulloblastoma, SHH-activated and TP53-wildtype]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 378: Line 831:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Medulloblastoma,_SHH-activated_and_TP53-mutant|Medulloblastoma, SHH-activated and TP53-mutant]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 387: Line 842:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Medulloblastoma,_non-WNT/non-SHH|Medulloblastoma, non-WNT/non-SHH]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 396: Line 853:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Medulloblastoma,_histologically_defined|Medulloblastoma, histologically defined]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 405: Line 864:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Atypical_teratoid/rhabdoid_tumour|Atypical teratoid/rhabdoid tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 414: Line 875:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Cribriform_neuroepithelial_tumour|Cribriform neuroepithelial tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 423: Line 886:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Embryonal_tumour_with_multilayered_rosettes|Embryonal tumour with multilayered rosettes]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 432: Line 897:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:CNS_neuroblastoma,_FOXR2-activated|CNS neuroblastoma, FOXR2-activated]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 441: Line 908:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:CNS_tumour_with_BCOR_internal_tandem_duplication|CNS tumour with BCOR internal tandem duplication]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 450: Line 919:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:CNS_embryonal_tumour_NEC/NOS|CNS embryonal tumour NEC/NOS]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 459: Line 930:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Pineoblastoma|Pineoblastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 468: Line 941:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Diffuse_meningeal_melanocytic_neoplasms:_Melanocytosis_and_melanomatosis|Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 477: Line 952:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Pituitary_adenoma_/_pituitary_neuroendocrine_tumour|Pituitary adenoma / pituitary neuroendocrine tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 486: Line 963:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Pituitary_blastoma|Pituitary blastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 495: Line 974:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Adamantinomatous_craniopharyngioma|Adamantinomatous craniopharyngioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 504: Line 985:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
 
 
|
 
|
 +
==== CHAPTER 4 (PERIPHERAL NEUROBLASTIC TUMOURS) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Ganglioneuroma|Ganglioneuroma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 522: Line 1,017:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Ganglioneuroblastoma,_intermixed|Ganglioneuroblastoma, intermixed]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 531: Line 1,028:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Neuroblastoma|Neuroblastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 540: Line 1,039:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Ganglioneuroblastoma,_nodular_(and_other_composite_neuroblastic_tumours)|Ganglioneuroblastoma, nodular (and other composite neuroblastic tumours)]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 549: Line 1,050:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
 
 
|
 
|
 +
==== CHAPTER 5 (EYE TUMOURS) ====
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Epibulbar_choristoma|Epibulbar choristoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 567: Line 1,082:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Epibulbar_osseous_choristoma|Epibulbar osseous choristoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 576: Line 1,093:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Phakomatous_choristoma|Phakomatous choristoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Conjunctival_junctional,_compound,_and_subepithelial_naevi|Conjunctival junctional, compound, and subepithelial naevi]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 585: Line 1,115:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Inflamed_juvenile_conjunctival_naevus|Inflamed juvenile conjunctival naevus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 594: Line 1,126:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Diffuse_choroidal_neurofibroma_and_ganglioneuroma|Diffuse choroidal neurofibroma and ganglioneuroma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 603: Line 1,137:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Lisch_nodule_(iris_hamartoma)|Lisch nodule (iris hamartoma)]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 612: Line 1,148:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Retinocytoma|Retinocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 621: Line 1,159:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Retinoblastoma|Retinoblastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 630: Line 1,170:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Medulloepithelioma|Medulloepithelioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 639: Line 1,181:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Pilocytic_astrocytoma_and_other_gliomas_of_the_optic_nerve|Pilocytic astrocytoma and other gliomas of the optic nerve]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 648: Line 1,192:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
 
 
|
 
|
 +
==== CHAPTER 6 (SOFT TISSUE AND BONE TUMOURS) ====
 +
|
 +
----
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Lipomatosis|Lipomatosis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 666: Line 1,224:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Lipoblastoma/lipoblastomatosis|Lipoblastoma/lipoblastomatosis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 675: Line 1,235:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Liposarcoma|Liposarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 684: Line 1,246:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Fasciitis/myositis|Fasciitis/myositis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 693: Line 1,257:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Fibrodysplasia_ossificans_progressiva|Fibrodysplasia ossificans progressiva]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 702: Line 1,268:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Fibroma_of_tendon_sheath|Fibroma of tendon sheath]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 711: Line 1,279:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Gardner_fibroma|Gardner fibroma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 720: Line 1,290:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Fibrous_hamartoma_of_infancy|Fibrous hamartoma of infancy]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 729: Line 1,301:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Lipofibromatosis|Lipofibromatosis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 738: Line 1,312:
 
|
 
|
 
|-
 
|-
 +
|[[PEDS5:Inclusion_body_infantile_digital_fibromatosis|Inclusion body infantile digital fibromatosis]]
 +
|Disease
 
|
 
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Juvenile_hyaline_fibromatosis_(hyaline_fibromatosis_syndrome)|Juvenile hyaline fibromatosis (hyaline fibromatosis syndrome)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Fibromatosis_colli|Fibromatosis colli]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Calcifying_aponeurotic_fibroma|Calcifying aponeurotic fibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Sinonasal_angiofibroma|Sinonasal angiofibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Plantar/palmar_fibromatoses|Plantar/palmar fibromatoses]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Dermatofibrosarcoma_protuberans|Dermatofibrosarcoma protuberans]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Desmoid_fibromatosis|Desmoid fibromatosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:EWSR1::SMAD3-positive_fibroblastic_tumour|EWSR1::SMAD3-positive fibroblastic tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Infantile_fibrosarcoma|Infantile fibrosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Paediatric_NTRK-rearranged_spindle_cell_neoplasm|Paediatric NTRK-rearranged spindle cell neoplasm]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Low-grade_fibromyxoid_sarcoma_/_sclerosing_epithelioid_fibrosarcoma|Low-grade fibromyxoid sarcoma / sclerosing epithelioid fibrosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Low-grade_myofibroblastic_sarcoma|Low-grade myofibroblastic sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Fibrous_histiocytoma|Fibrous histiocytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Plexiform_fibrohistiocytic_tumour_|Plexiform fibrohistiocytic tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Tenosynovial_giant_cell_tumour|Tenosynovial giant cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Capillary_malformations|Capillary malformations]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Venous_malformations|Venous malformations]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Arteriovenous_malformations|Arteriovenous malformations]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Intramuscular_vascular_anomalies|Intramuscular vascular anomalies]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Lymphatic_anomalies|Lymphatic anomalies]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Congenital_haemangioma|Congenital haemangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Infantile_haemangioma|Infantile haemangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Haemangioma_of_placenta|Haemangioma of placenta]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Lobular_capillary_haemangioma_(pyogenic_granuloma)|Lobular capillary haemangioma (pyogenic granuloma)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Epithelioid_haemangioma|Epithelioid haemangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Tufted_angioma_and_kaposiform_haemangioendothelioma|Tufted angioma and kaposiform haemangioendothelioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Papillary_intralymphatic_angioendothelioma_and_retiform_haemangioendothelioma|Papillary intralymphatic angioendothelioma and retiform haemangioendothelioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Pseudomyogenic_haemangioendothelioma|Pseudomyogenic haemangioendothelioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Kaposi_sarcoma|Kaposi sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Epithelioid_haemangioendothelioma|Epithelioid haemangioendothelioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Angiosarcoma|Angiosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Myofibroma_and_myopericytoma|Myofibroma and myopericytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Glomus_tumour_and_glomuvenous_malformation|Glomus tumour and glomuvenous malformation]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:EBV-associated_smooth_muscle_tumour|EBV-associated smooth muscle tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Rhabdomyoma|Rhabdomyoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Rhabdomyosarcomas|Rhabdomyosarcomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Ectomesenchymoma|Ectomesenchymoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Paediatric_gastrointestinal_stromal_tumour|Paediatric gastrointestinal stromal tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Schwannoma|Schwannoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Neurofibroma|Neurofibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Perineurioma|Perineurioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Hybrid_nerve_sheath_tumour|Hybrid nerve sheath tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Granular_cell_tumour|Granular cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Solitary_circumscribed_neuroma|Solitary circumscribed neuroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Ectopic_meningioma_and_meningothelial_hamartoma|Ectopic meningioma and meningothelial hamartoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Benign_triton_tumour_/_neuromuscular_choristoma|Benign triton tumour / neuromuscular choristoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Intramuscular/juxta-articular_myxoma|Intramuscular/juxta-articular myxoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Superficial_angiomyxoma|Superficial angiomyxoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Deep_angiomyxoma|Deep angiomyxoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Angiomatoid_fibrous_histiocytoma|Angiomatoid fibrous histiocytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Clear_cell_sarcoma_of_soft_tissue|Clear cell sarcoma of soft tissue]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Alveolar_soft_part_sarcoma|Alveolar soft part sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Extrarenal_rhabdoid_tumour|Extrarenal rhabdoid tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:PEComa|PEComa]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Synovial_sarcoma|Synovial sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Epithelioid_sarcoma|Epithelioid sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Myoepithelial_tumours_of_soft_tissue|Myoepithelial tumours of soft tissue]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Phosphaturic_mesenchymal_tumour|Phosphaturic mesenchymal tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Desmoplastic_small_round_cell_tumour|Desmoplastic small round cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Undifferentiated_sarcomas|Undifferentiated sarcomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Ewing_sarcoma|Ewing sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Round_cell_sarcoma_with_EWSR1::non-ETS_fusions|Round cell sarcoma with EWSR1::non-ETS fusions]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Sarcoma_with_BCOR_genetic_alterations|Sarcoma with BCOR genetic alterations]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Subungual_exostosis|Subungual exostosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Bizarre_parosteal_osteochondromatous_proliferation|Bizarre parosteal osteochondromatous proliferation]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Osteoblastoma|Osteoblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Osteoid_osteoma|Osteoid osteoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Chondromesenchymal_hamartoma_of_the_chest_wall_|Chondromesenchymal hamartoma of the chest wall]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Osteosarcoma|Osteosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Chondroblastoma|Chondroblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Osteochondroma|Osteochondroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Chondromyxoid_fibroma|Chondromyxoid fibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Enchondroma_and_enchondromatosis|Enchondroma and enchondromatosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Chondrosarcoma|Chondrosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Mesenchymal_chondrosarcoma_|Mesenchymal chondrosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Vascular_tumours_of_bone_|Vascular tumours of bone]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Aneurysmal_bone_cyst|Aneurysmal bone cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Giant_cell_tumour_of_bone|Giant cell tumour of bone]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Non-ossifying_fibroma|Non-ossifying fibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Notochordal_tumours|Notochordal tumours]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Simple_bone_cyst_|Simple bone cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Adamantinoma|Adamantinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Osteofibrous_dysplasia|Osteofibrous dysplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Fibrous_dysplasia|Fibrous dysplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 7 (GERM CELL TUMOURS) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[PEDS5:Intratubular_germ_cell_neoplasia_(male_gonadal)|Intratubular germ cell neoplasia (male gonadal)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Gonadoblastoma|Gonadoblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Germinoma/dysgerminoma/seminoma|Germinoma/dysgerminoma/seminoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Mature_cystic_teratoma|Mature cystic teratoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Extragonadal_teratoma|Extragonadal teratoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Monodermal_teratomas_(female_gonadal)|Monodermal teratomas (female gonadal)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Immature_teratoma_(female_gonadal)|Immature teratoma (female gonadal)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Prepubertal-type_testicular_teratoma|Prepubertal-type testicular teratoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Postpubertal-type_teratoma|Postpubertal-type teratoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Embryonal_carcinoma|Embryonal carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Yolk_sac_tumour|Yolk sac tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Fetus_in_fetu|Fetus in fetu]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Choriocarcinoma_(non-gestational)|Choriocarcinoma (non-gestational)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Malignant_mixed_germ_cell_tumours|Malignant mixed germ cell tumours]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 8 (RENAL AND MALE GENITAL TUMOURS) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[PEDS5:Paediatric_cystic_nephroma|Paediatric cystic nephroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Nephroblastoma|Nephroblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Renal_cell_carcinoma_with_MiT_translocations|Renal cell carcinoma with MiT translocations]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:ALK-rearranged_renal_cell_carcinoma|ALK-rearranged renal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Eosinophilic_solid_and_cystic_renal_cell_carcinoma|Eosinophilic solid and cystic renal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:SMARCB1-deficient_renal_medullary_carcinoma|SMARCB1-deficient renal medullary carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Metanephric_adenoma|Metanephric adenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Metanephric_adenofibroma_|Metanephric adenofibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Metanephric_stromal_tumour|Metanephric stromal tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Ossifying_renal_tumour_of_infancy|Ossifying renal tumour of infancy]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Mesoblastic_nephroma|Mesoblastic nephroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Clear_cell_sarcoma_of_the_kidney|Clear cell sarcoma of the kidney]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Malignant_rhabdoid_tumour_of_the_kidney|Malignant rhabdoid tumour of the kidney]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Anaplastic_sarcoma_of_the_kidney|Anaplastic sarcoma of the kidney]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Renal_Ewing_sarcoma|Renal Ewing sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Juvenile_granulosa_cell_tumour_of_the_testis|Juvenile granulosa cell tumour of the testis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 9 (FEMALE GENITAL TUMOURS) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[PEDS5:Ovarian_fibroma|Ovarian fibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Sclerosing_stromal_tumour|Sclerosing stromal tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Juvenile_granulosa_cell_tumour_of_the_ovary|Juvenile granulosa cell tumour of the ovary]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Sex_cord_tumour_with_annular_tubules_|Sex cord tumour with annular tubules]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Papillary_cystadenoma|Papillary cystadenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Sertoli-Leydig_cell_tumour|Sertoli-Leydig cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Gynandroblastoma|Gynandroblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Small_cell_carcinoma_of_the_ovary,_hypercalcaemic_type|Small cell carcinoma of the ovary, hypercalcaemic type]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Mesonephric_remnants_and_hyperplasia|Mesonephric remnants and hyperplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Mullerian_papilloma|Mullerian papilloma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Condyloma_acuminatum|Condyloma acuminatum]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Peritoneal_inclusion_cysts_|Peritoneal inclusion cysts]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 10 (BREAST TUMOURS) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[PEDS5:Fibroepithelial_tumours_|Fibroepithelial tumours]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Juvenile_fibroadenoma|Juvenile fibroadenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Juvenile_papillomatosis|Juvenile papillomatosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 11 (DIGESTIVE SYSTEM TUMOURS) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[PEDS5:Hepatoblastoma|Hepatoblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Fibrolamellar_variant_of_hepatocellular_carcinoma|Fibrolamellar variant of hepatocellular carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Paediatric_hepatocellular_carcinoma|Paediatric hepatocellular carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Mesenchymal_hamartoma|Mesenchymal hamartoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Calcifying_nested_stromal-epithelial_tumour|Calcifying nested stromal-epithelial tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Embryonal_sarcoma_of_the_liver|Embryonal sarcoma of the liver]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Hepatic_congenital_haemangioma|Hepatic congenital haemangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Hepatic_infantile_haemangioma|Hepatic infantile haemangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Hepatic_angiosarcoma|Hepatic angiosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Pancreatoblastoma|Pancreatoblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Pancreatic_acinar_cell_carcinoma|Pancreatic acinar cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Solid_pseudopapillary_neoplasm|Solid pseudopapillary neoplasm]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Gastroblastoma|Gastroblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Appendiceal_neuroendocrine_tumours|Appendiceal neuroendocrine tumours]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 12 (ENDOCRINE TUMOURS) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[PEDS5:Follicular_adenoma_of_the_thyroid|Follicular adenoma of the thyroid]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Papillary_thyroid_carcinoma|Papillary thyroid carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Medullary_thyroid_carcinoma|Medullary thyroid carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Spindle_epithelial_tumour_with_thymus-like_elements|Spindle epithelial tumour with thymus-like elements]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Parathyroid_adenoma|Parathyroid adenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Adrenal_cortical_tumours|Adrenal cortical tumours]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Sympathetic_paraganglioma|Sympathetic paraganglioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Parasympathetic_paraganglioma_(head_and_neck_paraganglioma)|Parasympathetic paraganglioma (head and neck paraganglioma)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Phaeochromocytoma|Phaeochromocytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Composite_phaeochromocytoma/paraganglioma|Composite phaeochromocytoma/paraganglioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Other_neuroendocrine_tumours|Other neuroendocrine tumours]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 13 (HEAD AND NECK TUMOURS) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[PEDS5:Squamous_cell_papilloma_of_the_larynx|Squamous cell papilloma of the larynx]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:White_sponge_naevus|White sponge naevus]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Congenital_granular_cell_epulis|Congenital granular cell epulis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Central_giant_cell_granuloma|Central giant cell granuloma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Odontogenic_tumours|Odontogenic tumours]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Ossifying_fibroma|Ossifying fibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Sinonasal_tract_myxoma|Sinonasal tract myxoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Nasal_dermoid_cyst|Nasal dermoid cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Nasopharyngeal_dermoid|Nasopharyngeal dermoid]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Sinonasal_chondromesenchymal_hamartoma|Sinonasal chondromesenchymal hamartoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Pleomorphic_adenoma|Pleomorphic adenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Mucoepidermoid_carcinoma|Mucoepidermoid carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Acinic_cell_carcinoma|Acinic cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Sialoblastoma|Sialoblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Nasopharyngeal_carcinoma|Nasopharyngeal carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:NUT_carcinoma|NUT carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Melanotic_neuroectodermal_tumour_of_infancy|Melanotic neuroectodermal tumour of infancy]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 14 (THORACIC TUMOURS) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[PEDS5:Fetal_lung_interstitial_tumour|Fetal lung interstitial tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Congenital_peribronchial_myofibroblastic_tumour|Congenital peribronchial myofibroblastic tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Pleuropulmonary_blastoma|Pleuropulmonary blastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Cardiac_rhabdomyoma|Cardiac rhabdomyoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 15 (SKIN TUMOURS) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[PEDS5:Hamartomas|Hamartomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Angiokeratoma|Angiokeratoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Epidermal_naevi|Epidermal naevi]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Pilomatricoma|Pilomatricoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Congenital_naevi|Congenital naevi]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Junctional,_compound,_and_dermal_naevi|Junctional, compound, and dermal naevi]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Blue_naevus|Blue naevus]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Spitz_naevus|Spitz naevus]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Pigmented_spindle_cell_naevus_(Reed_naevus)|Pigmented spindle cell naevus (Reed naevus)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Melanoma|Melanoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 16 (GENETIC TUMOUR SYNDROMES) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[PEDS5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[PEDS5:Neurofibromatosis_type_2|Neurofibromatosis type 2]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[PEDS5:Tuberous_sclerosis|Tuberous sclerosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Naevoid_basal_cell_carcinoma_syndrome_(Gorlin_syndrome)|Naevoid basal cell carcinoma syndrome (Gorlin syndrome)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Retinoblastoma_syndrome|Retinoblastoma syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[PEDS5:Hereditary_phaeochromocytoma-paraganglioma_syndromes|Hereditary phaeochromocytoma-paraganglioma syndromes]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:WAGR_syndrome|WAGR syndrome]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[PEDS5:Beckwith-Wiedemann_and_related_overgrowth_syndromes|Beckwith-Wiedemann and related overgrowth syndromes]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Familial_adenomatous_polyposis|Familial adenomatous polyposis]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[PEDS5:Lynch_syndrome|Lynch syndrome]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[PEDS5:Xeroderma_pigmentosum|Xeroderma pigmentosum]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Rothmund-Thomson_syndrome|Rothmund-Thomson syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[PEDS5:DICER1_syndrome|DICER1 syndrome]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[PEDS5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Constitutional_mismatch_repair_deficiency_syndrome|Constitutional mismatch repair deficiency syndrome]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[PEDS5:Rhabdoid_tumour_predisposition_syndrome|Rhabdoid tumour predisposition syndrome]]
 
|Disease
 
|Disease
 
|
 
|

Latest revision as of 14:11, 10 September 2024

Welcome!

For assignments, please see the "Author" column below (highlighted blue).

If empty (no name is present), please volunteer to create content for that disease!

To volunteer, please [Contact us] with your page of interest.

WHO Classification of Paediatric Tumours (5th Edition) Content
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes

CHAPTER 2 (HAEMATOLYMPHOID DISORDERS)
Chronic myeloid leukaemia (CML) Disease
Juvenile myelomonocytic leukaemia Disease
Refractory cytopenia of childhood Disease
Myelodysplastic syndrome with excess blasts Disease
Acute myeloid leukaemias (AMLs) defined by differentiation Disease
Acute myeloid leukaemias (AMLs) with defining genetic abnormalities Disease
Myeloid neoplasms associated with germline predisposition Disease
Myeloid proliferations associated with Down syndrome Disease
Mastocytosis Disease
B-lymphoblastic leukaemia/lymphoma Disease
T- and NK-lymphoblastic leukaemia/lymphoma Disease
Primary mediastinal large B-cell lymphoma Disease
Diffuse large B-cell lymphoma NOS Disease
EBV-positive diffuse large B-cell lymphoma Disease
Large B-cell lymphoma with IRF4 rearrangement Disease
Paediatric-type follicular lymphoma Disease
Paediatric nodal marginal zone lymphoma Disease
ALK-positive large B-cell lymphoma Disease
Lymphomatoid granulomatosis Disease
Plasmablastic lymphoma Disease
Mediastinal grey zone lymphoma Disease
Burkitt lymphoma Disease
Large B-cell lymphoma with 11q aberration Disease
Peripheral T-cell lymphoma NOS Disease
Aggressive NK-cell leukaemia Disease
Mycosis fungoides Disease
Primary cutaneous CD30-positive T-cell lymphoproliferative disorders Disease
Subcutaneous panniculitis-like T-cell lymphoma Disease
ALK-positive anaplastic large cell lymphoma Disease
Hepatosplenic T-cell lymphoma Disease
Systemic EBV-positive T-cell lymphoma of childhood Disease
Hydroa vacciniforme lymphoproliferative disorder Disease
Classic Hodgkin lymphoma Disease
Nodular lymphocyte-predominant Hodgkin lymphoma Disease
Langerhans cell histiocytosis and related disorders Disease
Primary immunodeficiency-associated lymphoproliferative disorders Disease
Posttransplant lymphoproliferative disorders Disease
HIV-associated lymphoproliferative disorders Disease

CHAPTER 3 (CNS TUMOURS)
Diffuse astrocytoma, MYB- or MYBL1-altered Disease
Angiocentric glioma Disease
Polymorphous low-grade neuroepithelial tumour of the young Disease
Diffuse low-grade glioma, MAPK pathway-altered Disease
Diffuse midline glioma, H3 K27-altered Disease
Diffuse hemispheric glioma, H3 G34-mutant Disease
Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype Disease
Infant-type hemispheric glioma Disease
Pilocytic astrocytoma Disease
High-grade astrocytoma with piloid features Disease
Pleomorphic xanthoastrocytoma Disease
Subependymal giant cell astrocytoma Disease
Astroblastoma, MN1-altered Disease
Ganglioglioma Disease
Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma Disease
Dysembryoplastic neuroepithelial tumour Disease
Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters Disease
Diffuse leptomeningeal glioneuronal tumour Disease
Multinodular and vacuolating neuronal tumour Disease
Supratentorial ependymoma Disease
Supratentorial ependymoma, ZFTA fusion-positive Disease
Supratentorial ependymoma, YAP1 fusion-positive Disease
Posterior fossa ependymoma Disease
Posterior fossa group A (PFA) ependymoma Disease
Posterior fossa group B (PFB) ependymoma Disease
Spinal ependymoma, MYCN-amplified Disease
Myxopapillary ependymoma Disease
Choroid plexus papilloma Disease
Atypical choroid plexus papilloma Disease
Choroid plexus carcinoma Disease
Medulloblastoma, WNT-activated Disease
Medulloblastoma, SHH-activated and TP53-wildtype Disease
Medulloblastoma, SHH-activated and TP53-mutant Disease
Medulloblastoma, non-WNT/non-SHH Disease
Medulloblastoma, histologically defined Disease
Atypical teratoid/rhabdoid tumour Disease
Cribriform neuroepithelial tumour Disease
Embryonal tumour with multilayered rosettes Disease
CNS neuroblastoma, FOXR2-activated Disease
CNS tumour with BCOR internal tandem duplication Disease
CNS embryonal tumour NEC/NOS Disease
Pineoblastoma Disease
Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis Disease
Pituitary adenoma / pituitary neuroendocrine tumour Disease
Pituitary blastoma Disease
Adamantinomatous craniopharyngioma Disease

CHAPTER 4 (PERIPHERAL NEUROBLASTIC TUMOURS)
Ganglioneuroma Disease
Ganglioneuroblastoma, intermixed Disease
Neuroblastoma Disease
Ganglioneuroblastoma, nodular (and other composite neuroblastic tumours) Disease

CHAPTER 5 (EYE TUMOURS)
Epibulbar choristoma Disease
Epibulbar osseous choristoma Disease
Phakomatous choristoma Disease
Conjunctival junctional, compound, and subepithelial naevi Disease
Inflamed juvenile conjunctival naevus Disease
Diffuse choroidal neurofibroma and ganglioneuroma Disease
Lisch nodule (iris hamartoma) Disease
Retinocytoma Disease
Retinoblastoma Disease
Medulloepithelioma Disease
Pilocytic astrocytoma and other gliomas of the optic nerve Disease

CHAPTER 6 (SOFT TISSUE AND BONE TUMOURS)
Lipomatosis Disease
Lipoblastoma/lipoblastomatosis Disease
Liposarcoma Disease
Fasciitis/myositis Disease
Fibrodysplasia ossificans progressiva Disease
Fibroma of tendon sheath Disease
Gardner fibroma Disease
Fibrous hamartoma of infancy Disease
Lipofibromatosis Disease
Inclusion body infantile digital fibromatosis Disease
Juvenile hyaline fibromatosis (hyaline fibromatosis syndrome) Disease
Fibromatosis colli Disease
Calcifying aponeurotic fibroma Disease
Sinonasal angiofibroma Disease
Plantar/palmar fibromatoses Disease
Dermatofibrosarcoma protuberans Disease
Desmoid fibromatosis Disease
EWSR1::SMAD3-positive fibroblastic tumour Disease
Infantile fibrosarcoma Disease
Paediatric NTRK-rearranged spindle cell neoplasm Disease
Low-grade fibromyxoid sarcoma / sclerosing epithelioid fibrosarcoma Disease
Inflammatory myofibroblastic tumour Disease
Low-grade myofibroblastic sarcoma Disease
Fibrous histiocytoma Disease
Plexiform fibrohistiocytic tumour Disease
Tenosynovial giant cell tumour Disease
Capillary malformations Disease
Venous malformations Disease
Arteriovenous malformations Disease
Intramuscular vascular anomalies Disease
Lymphatic anomalies Disease
Congenital haemangioma Disease
Infantile haemangioma Disease
Haemangioma of placenta Disease
Lobular capillary haemangioma (pyogenic granuloma) Disease
Epithelioid haemangioma Disease
Tufted angioma and kaposiform haemangioendothelioma Disease
Papillary intralymphatic angioendothelioma and retiform haemangioendothelioma Disease
Pseudomyogenic haemangioendothelioma Disease
Kaposi sarcoma Disease
Epithelioid haemangioendothelioma Disease
Angiosarcoma Disease
Myofibroma and myopericytoma Disease
Glomus tumour and glomuvenous malformation Disease
EBV-associated smooth muscle tumour Disease
Rhabdomyoma Disease
Rhabdomyosarcomas Disease
Ectomesenchymoma Disease
Paediatric gastrointestinal stromal tumour Disease
Schwannoma Disease
Neurofibroma Disease
Perineurioma Disease
Hybrid nerve sheath tumour Disease
Granular cell tumour Disease
Solitary circumscribed neuroma Disease
Ectopic meningioma and meningothelial hamartoma Disease
Benign triton tumour / neuromuscular choristoma Disease
Malignant peripheral nerve sheath tumour Disease
Intramuscular/juxta-articular myxoma Disease
Superficial angiomyxoma Disease
Deep angiomyxoma Disease
Angiomatoid fibrous histiocytoma Disease
Clear cell sarcoma of soft tissue Disease
Alveolar soft part sarcoma Disease
Extrarenal rhabdoid tumour Disease
PEComa Disease
Synovial sarcoma Disease
Epithelioid sarcoma Disease
Myoepithelial tumours of soft tissue Disease
Phosphaturic mesenchymal tumour Disease
Desmoplastic small round cell tumour Disease
Undifferentiated sarcomas Disease
Ewing sarcoma Disease
Round cell sarcoma with EWSR1::non-ETS fusions Disease
CIC-rearranged sarcoma Disease
Sarcoma with BCOR genetic alterations Disease
Subungual exostosis Disease
Bizarre parosteal osteochondromatous proliferation Disease
Osteoblastoma Disease
Osteoid osteoma Disease
Chondromesenchymal hamartoma of the chest wall Disease
Osteosarcoma Disease
Chondroblastoma Disease
Osteochondroma Disease
Chondromyxoid fibroma Disease
Enchondroma and enchondromatosis Disease
Chondrosarcoma Disease
Mesenchymal chondrosarcoma Disease
Vascular tumours of bone Disease
Aneurysmal bone cyst Disease
Giant cell tumour of bone Disease
Non-ossifying fibroma Disease
Notochordal tumours Disease
Simple bone cyst Disease
Adamantinoma Disease
Osteofibrous dysplasia Disease
Fibrous dysplasia Disease

CHAPTER 7 (GERM CELL TUMOURS)
Intratubular germ cell neoplasia (male gonadal) Disease
Gonadoblastoma Disease
Germinoma/dysgerminoma/seminoma Disease
Mature cystic teratoma Disease
Extragonadal teratoma Disease
Monodermal teratomas (female gonadal) Disease
Immature teratoma (female gonadal) Disease
Prepubertal-type testicular teratoma Disease
Postpubertal-type teratoma Disease
Embryonal carcinoma Disease
Yolk sac tumour Disease
Fetus in fetu Disease
Choriocarcinoma (non-gestational) Disease
Malignant mixed germ cell tumours Disease

CHAPTER 8 (RENAL AND MALE GENITAL TUMOURS)
Paediatric cystic nephroma Disease
Nephroblastoma Disease
Renal cell carcinoma with MiT translocations Disease
ALK-rearranged renal cell carcinoma Disease
Eosinophilic solid and cystic renal cell carcinoma Disease
SMARCB1-deficient renal medullary carcinoma Disease
Metanephric adenoma Disease
Metanephric adenofibroma Disease
Metanephric stromal tumour Disease
Ossifying renal tumour of infancy Disease
Mesoblastic nephroma Disease
Clear cell sarcoma of the kidney Disease
Malignant rhabdoid tumour of the kidney Disease
Anaplastic sarcoma of the kidney Disease
Renal Ewing sarcoma Disease
Juvenile granulosa cell tumour of the testis Disease

CHAPTER 9 (FEMALE GENITAL TUMOURS)
Ovarian fibroma Disease
Sclerosing stromal tumour Disease
Juvenile granulosa cell tumour of the ovary Disease
Sex cord tumour with annular tubules Disease
Papillary cystadenoma Disease
Sertoli-Leydig cell tumour Disease
Gynandroblastoma Disease
Small cell carcinoma of the ovary, hypercalcaemic type Disease
Mesonephric remnants and hyperplasia Disease
Mullerian papilloma Disease
Condyloma acuminatum Disease
Peritoneal inclusion cysts Disease

CHAPTER 10 (BREAST TUMOURS)
Fibroepithelial tumours Disease
Juvenile fibroadenoma Disease
Juvenile papillomatosis Disease

CHAPTER 11 (DIGESTIVE SYSTEM TUMOURS)
Hepatoblastoma Disease
Fibrolamellar variant of hepatocellular carcinoma Disease
Paediatric hepatocellular carcinoma Disease
Mesenchymal hamartoma Disease
Calcifying nested stromal-epithelial tumour Disease
Embryonal sarcoma of the liver Disease
Hepatic congenital haemangioma Disease
Hepatic infantile haemangioma Disease
Hepatic angiosarcoma Disease
Pancreatoblastoma Disease
Pancreatic acinar cell carcinoma Disease
Solid pseudopapillary neoplasm Disease
Gastroblastoma Disease
Appendiceal neuroendocrine tumours Disease

CHAPTER 12 (ENDOCRINE TUMOURS)
Follicular adenoma of the thyroid Disease
Papillary thyroid carcinoma Disease
Medullary thyroid carcinoma Disease
Spindle epithelial tumour with thymus-like elements Disease
Parathyroid adenoma Disease
Adrenal cortical tumours Disease
Sympathetic paraganglioma Disease
Parasympathetic paraganglioma (head and neck paraganglioma) Disease
Phaeochromocytoma Disease
Composite phaeochromocytoma/paraganglioma Disease
Other neuroendocrine tumours Disease

CHAPTER 13 (HEAD AND NECK TUMOURS)
Squamous cell papilloma of the larynx Disease
White sponge naevus Disease
Congenital granular cell epulis Disease
Central giant cell granuloma Disease
Odontogenic tumours Disease
Ossifying fibroma Disease
Sinonasal tract myxoma Disease
Nasal dermoid cyst Disease
Nasopharyngeal dermoid Disease
Sinonasal chondromesenchymal hamartoma Disease
Pleomorphic adenoma Disease
Mucoepidermoid carcinoma Disease
Acinic cell carcinoma Disease
Sialoblastoma Disease
Nasopharyngeal carcinoma Disease
NUT carcinoma Disease
Melanotic neuroectodermal tumour of infancy Disease

CHAPTER 14 (THORACIC TUMOURS)
Fetal lung interstitial tumour Disease
Congenital peribronchial myofibroblastic tumour Disease
Pleuropulmonary blastoma Disease
Cardiac rhabdomyoma Disease

CHAPTER 15 (SKIN TUMOURS)
Hamartomas Disease
Angiokeratoma Disease
Epidermal naevi Disease
Pilomatricoma Disease
Congenital naevi Disease
Junctional, compound, and dermal naevi Disease
Blue naevus Disease
Spitz naevus Disease
Pigmented spindle cell naevus (Reed naevus) Disease
Melanoma Disease

CHAPTER 16 (GENETIC TUMOUR SYNDROMES)
Neurofibromatosis type 1 Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Neurofibromatosis type 2 Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Tuberous sclerosis Disease
Naevoid basal cell carcinoma syndrome (Gorlin syndrome) Disease
Retinoblastoma syndrome Disease
Von Hippel-Lindau syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Hereditary phaeochromocytoma-paraganglioma syndromes Disease
WAGR syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Beckwith-Wiedemann and related overgrowth syndromes Disease
Familial adenomatous polyposis Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Lynch syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Xeroderma pigmentosum Disease
Rothmund-Thomson syndrome Disease
Li-Fraumeni syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
DICER1 syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
BAP1 tumour predisposition syndrome Disease
Constitutional mismatch repair deficiency syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Rhabdoid tumour predisposition syndrome Disease
Retrieved from "https://ccga.io/index.php?title=PEDS5:Volunteer_Assignments_and_Opportunities&oldid=15425"